Literature DB >> 21574950

DNA vaccines: a mini review.

Ratul Saha1, Sarah Killian, Robert S Donofrio.   

Abstract

DNA vaccines are a major breakthrough in the field of vaccination with several advantages over traditional vaccines. Unlike traditional vaccines, DNA vaccines stimulate both arms of the immune system offering long lasting immunity. DNA vaccines not only have the potential to fight against infectious diseases such as influenza and hepatitis but they can also be used to prevent autoimmune diseases such as multiple sclerosis. In general, this article is intended as a mini-review to discuss DNA vaccination, as well as patents on different types of DNA vaccines.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21574950     DOI： 10.2174/187221511796392114

Source DB:  PubMed          Journal:  Recent Pat DNA Gene Seq        ISSN： 1872-2156


  5 in total

1.  In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.

Authors:  Qingtao Wang; Wei Jiang; Yuhai Chen; Pengyu Liu; Chunjie Sheng; Shuai Chen; Hui Zhang; Changchuan Pan; Shijuan Gao; Wenlin Huang
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

2.  Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice.

Authors:  Sara Ayazian Mavi; Mohammad Hossein Modarressi; Mehdi Mohebali; Saeedeh Shojaee; Hojjat Zeraati; Aref Teimouri; Hossein Keshavarz
Journal:  Infect Drug Resist       Date:  2019-08-15       Impact factor: 4.003

3.  Molecular Cloning and Expression an 8-kDa Subunit of Antigen B from G1 strain of Echinococcus granulosus.

Authors:  Hakim Azizi; Bahram Kazemi; Mojgan Bandehpour; Mehdi Mohebali; Ali Khamesipour; Mojgan Aryaeipour; Mohammad Bagher Rokni
Journal:  Iran J Public Health       Date:  2015-07       Impact factor: 1.429

4.  Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis.

Authors:  Zhenchao Zhang; Yuhua Li; Mingyong Wang; Qing Xie; Pengju Li; Suqiong Zuo; Lingmin Kong; Chenxing Wang; Shuai Wang
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

5.  Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.

Authors:  Charu Aggarwal; Roger B Cohen; Matthew P Morrow; Kimberly A Kraynyak; Albert J Sylvester; Jocelyn Cheung; Kelsie Dickerson; Veronique Schulten; Dawson Knoblock; Elisabeth Gillespie; Joshua M Bauml; Jian Yan; Malissa Diehl; Jean Boyer; Michael Dallas; J Joseph Kim; David B Weiner; Jeffrey M Skolnik
Journal:  Vaccines (Basel)       Date:  2020-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.